Gan & Lee Pharmaceuticals launches third phase 3 trial of once-monthly bofanglutide
Mendus reports trial follow-up data supporting potential of vididencel in high-risk ovarian cancer
Novo Nordisk submits sNDA to FDA for for higher semaglutide injection dose
SK Biopharmaceuticals signs licence agreement with Wisconsin Alumni Research Foundation
Valneva reports positive final Phase 2 results for Lyme disease vaccine VLA15
Lunai Bioworks receives first LOI to license next-generation immune cell therapy
Novo Nordisk reports strong phase 2 results for amycretin in type 2 diabetes
Active Biotech to receive US patent for tasquinimod formulation
Sanofi and Regeneron's Dupixent approved in EU for chronic spontaneous urticaria
Clearmind Medicine advances global CMND-100 AUD trial with first patient enrolled in Israel